CEACAM6 and SLC2A1 may also play a role in IPMN tumor progression, with increased expression of these genes in high‐grade versus low‐ and intermediate‐grade IPMNs being previously observed [19, 22, 23, 24]. The gene discussed is SLC2A1; the disease is neoplasm.